174 related articles for article (PubMed ID: 27096096)
1. Natural killer cell immunotherapy to target stem-like tumor cells.
Grossenbacher SK; Canter RJ; Murphy WJ
J Immunother Cancer; 2016; 4():19. PubMed ID: 27096096
[TBL] [Abstract][Full Text] [Related]
2. NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype.
Ames E; Canter RJ; Grossenbacher SK; Mac S; Chen M; Smith RC; Hagino T; Perez-Cunningham J; Sckisel GD; Urayama S; Monjazeb AM; Fragoso RC; Sayers TJ; Murphy WJ
J Immunol; 2015 Oct; 195(8):4010-9. PubMed ID: 26363055
[TBL] [Abstract][Full Text] [Related]
3. Targeting Cancer Stem Cells with Natural Killer Cell Immunotherapy.
Luna JI; Grossenbacher SK; Murphy WJ; Canter RJ
Expert Opin Biol Ther; 2017 Mar; 17(3):313-324. PubMed ID: 27960589
[TBL] [Abstract][Full Text] [Related]
4. Bortezomib Augments Natural Killer Cell Targeting of Stem-Like Tumor Cells.
Luna JI; Grossenbacher SK; Sturgill IR; Ames E; Judge SJ; Bouzid LA; Darrow MA; Murphy WJ; Canter RJ
Cancers (Basel); 2019 Jan; 11(1):. PubMed ID: 30646520
[TBL] [Abstract][Full Text] [Related]
5. Human cancer cells with stem cell-like phenotype exhibit enhanced sensitivity to the cytotoxicity of IL-2 and IL-15 activated natural killer cells.
Yin T; Wang G; He S; Liu Q; Sun J; Wang Y
Cell Immunol; 2016 Feb; 300():41-5. PubMed ID: 26677760
[TBL] [Abstract][Full Text] [Related]
6. Enhanced targeting of stem-like solid tumor cells with radiation and natural killer cells.
Ames E; Canter RJ; Grossenbacher SK; Mac S; Smith RC; Monjazeb AM; Chen M; Murphy WJ
Oncoimmunology; 2015 Sep; 4(9):e1036212. PubMed ID: 26405602
[TBL] [Abstract][Full Text] [Related]
7. Concise Review: Targeting Cancer Stem Cells Using Immunologic Approaches.
Pan Q; Li Q; Liu S; Ning N; Zhang X; Xu Y; Chang AE; Wicha MS
Stem Cells; 2015 Jul; 33(7):2085-92. PubMed ID: 25873269
[TBL] [Abstract][Full Text] [Related]
8. A New Biological Feature of Natural Killer Cells: The Recognition of Solid Tumor-Derived Cancer Stem Cells.
Tallerico R; Garofalo C; Carbone E
Front Immunol; 2016; 7():179. PubMed ID: 27242786
[TBL] [Abstract][Full Text] [Related]
9. Immune targeting of cancer stem cells in gastrointestinal oncology.
Canter RJ; Grossenbacher SK; Ames E; Murphy WJ
J Gastrointest Oncol; 2016 Apr; 7(Suppl 1):S1-S10. PubMed ID: 27034806
[TBL] [Abstract][Full Text] [Related]
10. Expression and function of immune ligand-receptor pairs in NK cells and cancer stem cells: therapeutic implications.
Voutsadakis IA
Cell Oncol (Dordr); 2018 Apr; 41(2):107-121. PubMed ID: 29470831
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors.
Barbieri F; Thellung S; Ratto A; Carra E; Marini V; Fucile C; Bajetto A; Pattarozzi A; Würth R; Gatti M; Campanella C; Vito G; Mattioli F; Pagano A; Daga A; Ferrari A; Florio T
BMC Cancer; 2015 Apr; 15():228. PubMed ID: 25884842
[TBL] [Abstract][Full Text] [Related]
12. Targeted therapy against cancer stem cells.
Yang T; Rycaj K
Oncol Lett; 2015 Jul; 10(1):27-33. PubMed ID: 26170972
[TBL] [Abstract][Full Text] [Related]
13. The hitchhikers guide to cancer stem cell theory: markers, pathways and therapy.
Fábián Á; Vereb G; Szöllősi J
Cytometry A; 2013 Jan; 83(1):62-71. PubMed ID: 22997049
[TBL] [Abstract][Full Text] [Related]
14. Transmission of "split anergy" from tumor infiltrating to peripheral NK cells in a manner similar to "infectious tolerance".
Belyaev NN; Abramova VA
Med Hypotheses; 2014 Feb; 82(2):129-33. PubMed ID: 24332531
[TBL] [Abstract][Full Text] [Related]
15. IL-2-activated haploidentical NK cells restore NKG2D-mediated NK-cell cytotoxicity in neuroblastoma patients by scavenging of plasma MICA.
Kloess S; Huenecke S; Piechulek D; Esser R; Koch J; Brehm C; Soerensen J; Gardlowski T; Brinkmann A; Bader P; Passweg J; Klingebiel T; Schwabe D; Koehl U
Eur J Immunol; 2010 Nov; 40(11):3255-67. PubMed ID: 21061445
[TBL] [Abstract][Full Text] [Related]
16. Annexin A3 as a potential target for immunotherapy of liver cancer stem-like cells.
Pan QZ; Pan K; Wang QJ; Weng DS; Zhao JJ; Zheng HX; Zhang XF; Jiang SS; Lv L; Tang Y; Li YQ; He J; Liu Q; Chen CL; Zhang HX; Xia JC
Stem Cells; 2015 Feb; 33(2):354-66. PubMed ID: 25267273
[TBL] [Abstract][Full Text] [Related]
17. NK cells control breast cancer and related cancer stem cell hematological spread.
Tallerico R; Conti L; Lanzardo S; Sottile R; Garofalo C; Wagner AK; Johansson MH; Cristiani CM; Kärre K; Carbone E; Cavallo F
Oncoimmunology; 2017; 6(3):e1284718. PubMed ID: 28405511
[TBL] [Abstract][Full Text] [Related]
18. Cancer stem cells and their potential implications for the treatment of solid tumors.
Grotenhuis BA; Wijnhoven BP; van Lanschot JJ
J Surg Oncol; 2012 Aug; 106(2):209-15. PubMed ID: 22371125
[TBL] [Abstract][Full Text] [Related]
19. Cancer Stem Cells: Emerging Key Players in Immune Evasion of Cancers.
Lei MML; Lee TKW
Front Cell Dev Biol; 2021; 9():692940. PubMed ID: 34235155
[TBL] [Abstract][Full Text] [Related]
20. Cell therapy: achievements and perspectives.
Bordignon C; Carlo-Stella C; Colombo MP; De Vincentiis A; Lanata L; Lemoli RM; Locatelli F; Olivieri A; Rondelli D; Zanon P; Tura S
Haematologica; 1999 Dec; 84(12):1110-49. PubMed ID: 10586214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
